Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2008
06/05/2008US20080131501 enhanced immediate release formulations of topiramate, in which 80% of the active ingredient is released in the period of time of not more than 30 min. These formulations may be advantageously used for the treatment of acute neurological conditions, such as migraine.
06/05/2008US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
06/05/2008US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases
06/05/2008US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease
06/05/2008DE102006056740A1 Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung Cyclic substituted 3,5-dicyano-2-thiopyridines and their use
06/05/2008DE102006056739A1 Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung Substituted 4-amino-3,5-dicyano-2-thiopyridines, and their use
06/05/2008CA2671080A1 Carboxylic acid derivatives
06/05/2008CA2670976A1 Cyclic amine compound
06/05/2008CA2670957A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways
06/05/2008CA2670736A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
06/05/2008CA2670587A1 Assay
06/05/2008CA2670573A1 Diaminocyclohexane and diaminocyclopentane derivatives
06/05/2008CA2670563A1 Methods for treating hypercholesterolemia
06/05/2008CA2669343A1 Nutritional supplement
06/05/2008CA2668713A1 Novel phenyl-isoxazol-3-ol derivative
06/05/2008CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives
06/04/2008EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
06/04/2008EP1927368A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/04/2008EP1927367A1 Novel pharmaceutical using anti-hla antibody
06/04/2008EP1927361A1 Visceral fat accumulation inhibitor
06/04/2008EP1927360A1 Visceral fat accumulation inhibitor
06/04/2008EP1927357A2 Low hygroscopic aripiprazole (crystal E) drug substance and processes for the preparation thereof
06/04/2008EP1927356A1 Low hygroscopic aripiprazole (crystal D) drug substance and processes for the preparation thereof
06/04/2008EP1927355A1 Low hygroscopic aripiprazole (crystal F) drug substance and processes for the preparation thereof
06/04/2008EP1927352A2 Therapeutic methods and compositions involving isoflavones
06/04/2008EP1926720A1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
06/04/2008EP1926712A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
06/04/2008EP1648483B1 Composition for treating and/or preventing insulin resistance
06/04/2008EP1474119B1 Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta
06/04/2008EP1463754B1 Cystine-knot fold protein
06/04/2008EP1448089A4 Devices and methods for the restoration of a spinal disc
06/04/2008EP1343775B1 Piperazine derivatives
06/04/2008EP1192182B1 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
06/04/2008EP1019082B2 Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections
06/04/2008CN101193913A Adiponectin variants
06/04/2008CN101193896A Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors
06/04/2008CN101193889A Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehyftogenase type I
06/04/2008CN101193885A Benzofuran derivative as 5-HT6 receptor inhibitor
06/04/2008CN101193874A 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming PPAR ligands, methods for production and the use thereof in the form of drugs
06/04/2008CN101193656A Novel triglyceride reducing agent
06/04/2008CN101193649A Use of plant cell membrane for the for the treatment of obesity
06/04/2008CN101193632A Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/04/2008CN101193561A Dietary fiber composition comprising glucomannan, xanthan gum, and alginate
06/04/2008CN101190319A Traditional Chinese medicine for treating diabetes
06/04/2008CN101190318A Traditional Chinese medicine for treating I-type and II-type diabetes
06/04/2008CN101190316A Traditional Chinese medicine composition for treating infantile malnutrition
06/04/2008CN101190313A Hypoylycemic health tea and preparation method
06/04/2008CN101190285A Health-care tea for preventing stroke and its making method
06/04/2008CN101190281A Prune tree extract and preparation method and application thereof
06/04/2008CN101190278A Antilipemic health-care tea and its making method
06/04/2008CN101190276A Method for separating and extracting sweet tea tannins
06/04/2008CN101190264A Fat-reducing body-building traditional Chinese medicine composition
06/04/2008CN101190262A Traditional Chinese medicine for treating diabetes and preparation method and application thereof
06/04/2008CN101190253A Medicinal composition containing mongolian snakegourd and notoginseng
06/04/2008CN101190248A Long chain fatty milk in camelina sativa oil orally-administered or injection preparations
06/04/2008CN101190238A Method for using shrimp shell mud fermentation to produce biological calcium product
06/04/2008CN101190235A Felidae bone insteading of tiger bone medicine, calcium replenishing agent and biological inorganic salt precipitating agent
06/04/2008CN101190226A Vitamin B2 chewable tablets for dog or cat
06/04/2008CN101190224A Vitamin B1 chewable tablets for dog or cat
06/04/2008CN101190221A Vitamin B6 chewable tablets for dog or cat
06/04/2008CN101190215A Vitamin C chewable tablets for dog or cat
06/04/2008CN101190189A Low molecule heparin mucous membrane adhesive tablet preparations and preparation method thereof
06/04/2008CN101190179A Enteric medicinal composition for treating diabetes and preparation method thereof
06/04/2008CN101190013A Formula of honey crisp-fried bean and processing method
06/04/2008CN101190007A Nutrition food containing bran
06/04/2008CN101189999A Persimmon leaf health tea
06/04/2008CN101189995A Acanthopanax giraldii harms tea
06/04/2008CN101189988A Method for concentrating coix seed oil capable of reducing blood fat and low density cholesterol
06/04/2008CN101189975A High-grade nutritious calcium replenishing wheaten food
06/04/2008CN101189960A Method for breeding selenium-rich livestock and fowls
06/04/2008CN100391964C Rehmannia root oligose and its extracting method
06/04/2008CN100391953C Medicinal use and extraction of cis-ligusticum lactone
06/04/2008CN100391522C Diabetes treating medicine
06/04/2008CN100391492C Burdock microecological formulation
06/04/2008CN100391491C Medicine composition for treating cardiovascular diseases and preparation method thereof
06/04/2008CN100391489C Medicinal composition containing borneol
06/04/2008CN100391481C American ginseng soft capsule
06/04/2008CN100391465C Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic
06/04/2008CN100391464C Pharmaceutical compositions comprising active vitamin D compounds
06/04/2008CN100391439C Immunopotentiators
06/04/2008CN100391376C Cigarette made from mulberry leaf
06/04/2008CN100391354C Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
06/03/2008US7381790 Copolymers for suppression of autoimmune diseases, and methods of use
06/03/2008US7381733 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
06/03/2008US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
06/03/2008US7381719 To treat obesity and Related Diseases; oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; weight loss while maintaining or minimizing the loss of lean muscle mass; 6-[4-(2-Benzylamino-ethyl)-phenoxy]-nicotinamide
06/03/2008US7381702 Methods of treating diabetes mellitus
06/03/2008US7381424 Hydrostatic delivery system for controlled delivery of agent
06/03/2008US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders
06/03/2008CA2501587C Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed
06/03/2008CA2435954C Preparation of non-crystalline atorvastatin calcium
06/03/2008CA2389360C Urea derivatives as anti-inflammatory agents
06/03/2008CA2368186C Use of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
06/03/2008CA2339628C Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
06/03/2008CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil
06/03/2008CA2285552C Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate
05/2008
05/31/2008CA2669247A1 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity)
05/29/2008WO2008064259A2 Solid dispersion composition comprising fluvastatin
05/29/2008WO2008063766A2 Amorphous ezetimibe and the production thereof
05/29/2008WO2008063118A1 Improving release of insulin
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 1298